Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 59, Issue 9, 2010, Pages 1365-1371

  Reyes Soffer, Gissette ^a   Holleran, Steve ^a   Di Tullio, Marco R ^a   Homma, Shunichi ^a   Boden Albala, Bernadette ^a   Ramakrishnan, Rajasekhar ^a   Elkind, Mitchell S ^a   Sacco, Ralph L ^a   Ginsberg, Henry N ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BODY MASS; BRACHIAL ARTERY; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; BLOOD; BLOOD FLOW; BLOOD FLOW VELOCITY; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; VASCULAR ENDOTHELIUM;

LIPID;

BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BODY MASS INDEX; BRACHIAL ARTERY; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPIDS; MALE; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS;

EID: 77956638398     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.12.023     Document Type: Article

References (70)

1. Hu F.B., Stampfer M.J., and Haffner S.M. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes Diabetes Care 25 2002 1129 1134
2. Expert Panel on Detection EaToHBCiA Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
3. Haffner S.M., Lehto S., and Ronnemaa T. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
4. Bucala R., Tracey K.J., and Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes J Clin Invest 87 1991 432 438
5. Goldberg R.B. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications J Clin Endocrinol Metab 94 2009 3171 3182
6. Blankenberg S., Barbaux S., and Tiret L. Adhesion molecules and atherosclerosis Atherosclerosis 170 2003 191 203
7. Anderson T.J., Gerhard M.D., and Meredith I.T. Systemic nature of endothelial dysfunction in atherosclerosis Am J Cardiol 75 1995 71B 74B
8. Nabel E.G., Selwyn A.P., and Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis J Am Coll Cardiol 16 1990 349 356
9. Widlansky M.E., Gokce N., and Keaney J.F. Jr The clinical implications of endothelial dysfunction J Am Coll Cardiol 42 2003 1149 1160
10. Celermajer D.S., Sorensen K.E., and Bull C. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction J Am Coll Cardiol 24 1994 1468 1474
11. Shechter M., Issachar A., and Marai I. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease Int J Cardiol 2008
12. Reddy K.G., Nair R.N., and Sheehan H.M. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis J Am Coll Cardiol 23 1994 833 843
13. Reaven G.M. Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
14. Diamant M., and Tushuizen M. The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD Curr Diab Rep 6 2006 279 286
15. Rossi R., Cioni E., and Nuzzo A. Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women Diabetes Care 28 2005 702 707
16. Johnstone M.T., Creager S.J., and Scales K.M. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus Circulation 90 1993 1109 1110
17. Jarvisalo M.J., Raitakari M., and Toikka J.O. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes Circulation 109 2004 1750 1755
18. Meeking D.R., Cummings M.H., and Thorne S. Endothelial dysfunction in type 2 diabetic subjects with and without microalbuminuria Diabet Med 16 1999 841 847
19. Yu H.I., Sheu W.H., and Lai C.J. Endothelial dysfunction in type 2 diabetes mellitus subjects with peripheral artery disease Int J Cardiol 78 2001 19 25
20. Green D.J., Maiorana A.J., and Tschakovsky M.E. Relationship between changes in brachial artery flow-mediated dilation and basal release of nitric oxide in subjects with type 2 diabetes Am J Physiol Heart Circ Physiol 291 2006 H1193 H1199
21. Adams M.R. Clinical assessment of endothelial function Endothelium 13 2006 367 374
22. Correti M.C., Anderson T.J., and Benjamin E.J. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
23. Djaberi R., Beishuizen E.D., and Pereira A.M. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus Diabetologia 51 2008 1581 1593
24. Anderson T.J., Uehata A., and Gerhard M.D. Close relation of endothelial function in the human coronary and peripheral circulations J Am Coll Cardiol 26 1995 1235 1241
25. Takase B., Hamabe A., and Satomura K. Close relationship between the vasodilator to acetylcholine in the brachial and coronary artery in suspected coronary artery disease Int J Cardiol 105 2005 58 66
26. Neunteufl T., Katzenschlager R., and Hassan A. Systemic endothelial dysfunction is related to the extent and severity of CAD Atherosclerosis 129 1997 111 118
27. Lieberman E.H., Gerhard M.D., and Uehata A. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease Am J Cardiol 78 1996 1210 1214
28. Wu W.C., Sharma S.C., and Choudhary G. Flow-mediated vasodilation predicts the presence and extent of coronary artery disease assessed by stress thallium imaging J Nucl Cardiol 12 2005 538 544
29. Amir O., Jaffe R., and Shiran A. Brachial reactivity and extent of coronary artery disease in patients with first ST-elevation acute myocardial infarction Am J Cardiol 98 2006 754 757
30. Yeboah J., Crouse J.R., and Hsu F.C. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study Circulation 115 2007 2390 2397
31. Yeboah J., Folsom A.R., and Burke G.L. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study. The Multi-Ethnic Study of Atherosclerosis Circulation 120 2009 502 509
32. Karatzis E.N., Ikonomidis I., and Vamvakou G.D. Long-term prognostic role of flow-mediated dilation of the brachial artery after acute coronary syndromes without ST elevation Am J Cardiol 98 2006 1424 1428
33. Kitta Y., Nakamura T., and Kodama Y. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis J Am Coll Cardiol 46 2005 648 655
34. Akcakoyun M., Kargin R., and Tanalp A.C. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study Coron Artery Dis 19 2008 337 343
35. Bhargava K., Hansa G., and Bansal M. Endothelium dependent brachial artery flow mediated vasodilation in patients with diabetes mellitus with and without coronary artery disease JAPI 51 2003 355 358
36. Kirma C., Akcakoyun M., and Esen A.M. Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease Circ J 71 2007 698 702
37. Miettinen H., Lehto S., and Salomaa V. Impact of diabetes on mortality after the first myocardial infarction: the FINMONICA Myocardial Infarction Register Study Group Diabetes Care 21 1998 69 75
38. Sprafka J.M., Burke G.L., and Folsom A.R. Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey Diabetes Care 14 1991 537 543
39. Sacco R.L., Boden-Albala B., and Abel G. Race-ethnic disparities in the impact of stroke risk factors: the Northern Manhattan stroke study Stroke 32 2001 1725 1731
40. Pulerwitz T., Grahame-Clarke C., and Rodriguez C.J. Association of increased body mass index and impaired endothelial function among Hispanic women Am J Cardiol 97 2006 68 70
41. Reyes-Soffer G., Holleran S., and Karmally W. Measures of postprandial lipoproteins are not associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus J Lipid Res 2009
42. Nagashima K., Lopez C., and Donovan D. Effects of the PPAR agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus JCI 2005 1323 1332
43. Friedewald W.T., Levy R.I., and Drederickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative centrifuge Clin Chem 18 1972 499 502
44. Rodriguez C.J., Miyake Y., and Grahame-Clarke C. Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus Am J Cardiol 96 2005 1273 1277
45. Henry R.M., Ferreira I., and Kostense P.J. Type II diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not Arteriosclerosis 174 2004 49 56
46. Su Y., Liu X.M., and Sun Y.M. Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus Am J Cardiol 102 2008 497 498
47. Li X.P., Zhao S.P., and Zhang X.Y. Protective effect of high density lipoprotein on endothelium-dependent vasodilatation Int J Cardiol 31 2000 231 236
48. Maggi F.M., Raselli S., and Grigore L. Lipoprotein remnants and endothelial dysfunction in the postprandial phase J Clin Endocrinol Metab 89 2004 2946 2950
49. Nadar S., Blann A.D., and Lip G.Y. Endothelial dysfunction: methods of assessment and application to hypertension Curr Pharm Des 10 2009 3591 3605
50. Tanriverdi H., Evrengul H., and Kuru O. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries Circulation 70 2006 593 599
51. Wilson A.M., Ryan M.C., and Boyle A.J. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen Int J Cardiol 106 2006 291 297
52. Paffen E., and DeMaat M.P. C-reactive protein in atherosclerosis: a causal factor? Cardiovasc Res 71 2006 30 39
53. Vitale C., Cerquetani E., and Wajngarten M. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy Ital Heart J 4 2003 627 632
54. Ridker P.M., Buring J.E., and Rifai N. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 2007 611 619
55. Williams S.B., Goldfine A.B., and Timimi F.K. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo Circulation 97 1998 1695 1701
56. Title L.M., Cummings P.M., and Giddens K. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E J Am Coll Cardiol 36 2000 2185 2191
57. Bechman J.A., Goldfine A.B., and Gordon M.B. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans Circulation 103 2001 1618 1623
58. Uribarri J., Stirban A., and Sander D. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects Diabetes Care 30 2007 2579 2582
59. Antoniades C., Tousoulis D., and Tountas C. Vascular endothelium and inflammatory process, in patients with combined type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C Diabet Med 21 2004 552 558
60. Vehkavaara S., Makimattila S., and Schienzka A. Insulin therapy improves endothelial function in type 2 diabetes Artheroscler Thromb Vasc Biol 20 2000 545 550
61. Martens F.M., Visseren F.L., and de Koning E. Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes Cardiovasc Pharmacol 46 2005 773 778
62. Kelly A.S., Thelen A.M., and Kaiser D.R. Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus Vasc Med 12 2007 311 318
63. Manzella D., Grella R., and Abbatecola A.M. Repaglinide administration improves brachial reactivity in type 2 diabetic patients Diabetes Care 28 2005 366 371
64. Bagg W., Whailey G.A., and Gamble G. Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes Intern Med J 31 2001 322 328 (Pubitemid 34225185)
65. UKPDS Group Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 837 853
66. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (URPDS 34) Lancet 352 1998 854 865
67. DIGAMI - Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction- Study Group Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus BMJ 314 1997 1512 1515
68. Action to Control Cardiovascular Risk in Diabetes Study Group GHC Miller M.E., and Byington B.P. Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
69. ADVANCE Collaborative Group Patel A., and MacMahon S. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
70. Duckworth W., Abraira C., and Moritz T. Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139